Q-Line Biotech Limited

<table><tr><td>Manufacturing Plant</td><td>Plot No. 2, Pocket H, Sector 5, DSIIDC, Bawana Industrial Area, North West Delhi, Delhi, 110039</td></tr><tr><td>Manufacturing Plant</td><td>Plot No 3, Pocket H, Sector 5, DSIIDC, Bawana Industrial Area, North West Delhi, Delhi, 110039</td></tr><tr><td>Branch office & Warehouse</td><td>C-108, Nariana Industrial Area, Phase - I, New Delhi - 110028</td></tr><tr><td>Used for scrap and unused material</td><td>298, Pocket - D, Sector - 5, Bawana Industrial Complex, Bawana, Delhi - 110039, India</td></tr><tr><td>Branch Office</td><td>1-FR, FB-161, 1766 Raj Danga Main Rd, Kolkata, Kolkata, West Bengal - 700107, India</td></tr><tr><td>Branch Office</td><td>Anand Bhavan, Plot No. 441/1621/1807 Divyanagar, Nuagoan, Side Lane of Indian Oil Petrol Pump, Nuagaon, Bhubaneshwar, Odisha, Khordha, Odisha - 751002</td></tr></table>

Our Geographical presence spans in some states of India and we export as well. The state wise sale during the last 3 years on standalone basis is as per below table:-

(In Lakhs)

<table><thead><tr><th>State</th><th>24-25</th><th>%</th><th>FY24</th><th>%</th><th>FY23</th><th>%</th></tr></thead><tbody><tr><td>Uttar Pradesh</td><td>22,665.88</td><td>72.25%</td><td>13,430.66</td><td>65.95%</td><td>12,520.10</td><td>68.51%</td></tr><tr><td>Madhya Pradesh</td><td>1,431.14</td><td>4.56%</td><td>903.55</td><td>4.44%</td><td>963.23</td><td>5.27%</td></tr><tr><td>Rajasthan</td><td>852.11</td><td>2.72%</td><td>820.60</td><td>4.03%</td><td>776.98</td><td>4.25%</td></tr><tr><td>Odisha</td><td>1,050.10</td><td>3.35%</td><td>785.58</td><td>3.86%</td><td>505.16</td><td>2.76%</td></tr><tr><td>Kerala</td><td>1,182.65</td><td>3.77%</td><td>581.13</td><td>2.85%</td><td>389.25</td><td>2.13%</td></tr><tr><td>West Bengal</td><td>633.80</td><td>2.02%</td><td>500.07</td><td>2.46%</td><td>601.74</td><td>3.29%</td></tr><tr><td>Haryana</td><td>886.26</td><td>2.83%</td><td>759.56</td><td>3.73%</td><td>66.68</td><td>0.36%</td></tr><tr><td>Bihar</td><td>404.94</td><td>1.29%</td><td>680.15</td><td>3.34%</td><td>494.36</td><td>2.71%</td></tr><tr><td>Delhi</td><td>400.95</td><td>1.28%</td><td>478.61</td><td>2.35%</td><td>429.98</td><td>2.35%</td></tr><tr><td>Maharashtra</td><td>442.80</td><td>1.41%</td><td>367.15</td><td>1.80%</td><td>329.97</td><td>1.81%</td></tr><tr><td>Assam</td><td>297.32</td><td>0.95%</td><td>288.75</td><td>1.42%</td><td>268.42</td><td>1.47%</td></tr><tr><td>Gujarat</td><td>360.51</td><td>1.15%</td><td>152.57</td><td>0.75%</td><td>332.25</td><td>1.82%</td></tr><tr><td>Others</td><td>762.64</td><td>2.43%</td><td>616.23</td><td>3.03%</td><td>595.53</td><td>3.26%</td></tr></tbody><tfoot><tr><td>Grand Total</td><td>31,371.09</td><td>100.00%</td><td>20,364.61</td><td>100.00%</td><td>18,273.63</td><td>100.00%</td></tr></tfoot></table>

## Key Performance Indicators of our Company (Consolidated)

(â‚¹ In Lakhs except percentages and ratios)

<table><thead><tr><th>Key Financial Performance</th><th>FY 2024-25</th><th>FY 2023-24</th><th>FY 2022-23</th></tr></thead><tbody><tr><td>Revenue from operations<sup>(1)</sup></td><td>31378.04</td><td>20364.61</td><td>18273.63</td></tr><tr><td>EBITDA<sup>(2)</sup></td><td>7132.12</td><td>3762.50</td><td>3297.72</td></tr><tr><td>EBITDA Margin<sup>(3)</sup></td><td>22.73%</td><td>18.48%</td><td>18.05%</td></tr><tr><td>PAT<sup>(4)</sup></td><td>2813.09</td><td>3444.92</td><td>3209.71</td></tr><tr><td>PAT Margin<sup>(5)</sup></td><td>8.97%</td><td>16.92%</td><td>17.56%</td></tr><tr><td>Debt Equity Ratio<sup>(6)</sup></td><td>0.87</td><td>0.60</td><td>0.58</td></tr><tr><td>RoE(%)<sup>(7)</sup></td><td>17.66%</td><td>19.25%</td><td>22.14%</td></tr><tr><td>RoCE (%)<sup>(8)</sup></td><td>23.74%</td><td>21.29%</td><td>25.20%</td></tr></tbody></table>

**Notes:**

(1) Revenue from operations means revenue from sales, service and other operating revenues

(2) EBITDA means Earnings before interest, taxes, depreciation and amortization expense, arrived at by obtaining the profit before tax/ (loss) for the year and adding back finance costs, depreciation and amortization and impairment expense and reducing Interest income, and Profit on sale of investment and after eliminating the effect of extra ordinary and exceptional items.

(3) 'EBITDA Margin' is calculated as EBITDA divided by Revenue from Operations

(4) PAT is calculated as Profit before tax - Tax Expenses

(5) 'PAT Margin' is calculated as PAT for the period/year divided by revenue from operations.

(6) Debt Equity Ratio: is calculated as Net debt divided by total equity. Net debt is the result of Debt (current & non-current borrowings); total equity means Net worth

(7) ROE is calculated as PAT (excluding of extra ordinary losses) as divided by Net worth.

(8) ROCE is calculated as EBIT divided by capital employed where (i) EBIT means PAT + Tax Expenses + Finance Cost (ii) Capital employed means Net worth + total current & non-current borrowings+DTL-DTA as appearing in financial statements

## STATEMENT OF SIGNIFICANT ACCOUNTING POLICIES

For details in respect of Statement of Significant Accounting Policies, please refer to Restated Financial Statements beginning on page 179 of this Draft Red Herring Prospectus.

248